Literature DB >> 28063371

Individual dose due to radioactivity accidental release from fusion reactor.

Baojie Nie1, Muyi Ni2, Shiping Wei1.   

Abstract

As an important index shaping the design of fusion safety system, evaluation of public radiation consequences have risen as a hot topic on the way to develop fusion energy. In this work, the comprehensive public early dose was evaluated due to unit gram tritium (HT/HTO), activated dust, activated corrosion products (ACPs) and activated gases accidental release from ITER like fusion reactor. Meanwhile, considering that we cannot completely eliminate the occurrence likelihood of multi-failure of vacuum vessel and tokamak building, we conservatively evaluated the public radiation consequences and environment restoration after the worst hypothetical accident preliminarily. The comparison results show early dose of different unit radioactivity release under different conditions. After further performing the radiation consequences, we find it possible that the hypothetical accident for ITER like fusion reactor would result in a level 6 accident according to INES, not appear level 7 like Chernobyl or Fukushima accidents. And from the point of environment restoration, we need at least 69 years for case 1 (1kg HTO and 1000kg dust release) and 34-52years for case 2 (1kg HTO and 10kg-100kg dust release) to wait the contaminated zone drop below the general public safety limit (1mSv per year) before it is suitable for human habitation.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dose; Dust; Environment restoration; Fusion reactor; Tritium

Mesh:

Substances:

Year:  2016        PMID: 28063371     DOI: 10.1016/j.jhazmat.2016.12.018

Source DB:  PubMed          Journal:  J Hazard Mater        ISSN: 0304-3894            Impact factor:   10.588


  1 in total

1.  Cyclooxygenase‑2‑mediated upregulation of heme oxygenase 1 mitigates the toxicity of deuterium‑tritium fusion radiation.

Authors:  Xiaoyao Yang; Hui Liu; Xu Jiang; Chufeng Jin; Zhao Xu; Taosheng Li; Zhigang Wang; Jun Wang
Journal:  Int J Mol Med       Date:  2018-08-01       Impact factor: 4.101

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.